Skip to main content
SpringerLink
Log in

Surgical Management of Breast Cancer After Preoperative Systemic Treatment

  • Chapter
  • First Online:
Personalized Treatment of Breast Cancer

  • 1157 Accesses

Abstract

Surgery following neoadjuvant systemic therapy involves complex decision making within the entire multidisciplinary team. The selection of which systemic therapy to use (i.e. endocrine therapy, chemotherapy, anti-HER2 agents) and the role of radiotherapy therapy must be carefully considered on a case-by-case basis. Tumour size before, during and after the systemic therapy needs to be carefully and accurately measured by the most appropriate imaging technique(s), before deciding on the final surgical approach. For the small percentage of patients whose tumour progresses during treatment or where there is no volume reduction and the tumour remains unsuitable for breast-conserving surgery, mastectomy with or without reconstruction remains an option. For the remaining patients, there are various surgical options available from standard breast-conserving surgery to oncoplastic breast-conserving surgery. The choice will be determined by a number of factors including the size of the tumour, surgical decision making regarding the need to remove the entire initial tumour volume or residual tumour volume, the size of the breast, the location of the tumour, the radiologic appearance after neoadjuvant therapy and the tumour subtype and patient’s concerns.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. De Lena M, Zucali R, Viganotti G, Valagussa P, Bonadonna G (1978) Combined chemotherapy radiotherapy approach in locally advanced breast cancer. Cancer Chemother Pharmacol 1(1):53–59

    Article  PubMed  Google Scholar 

  2. Schick P, Goodstein J, Moor J, Butler J, Senter KL (1983) Preoperative chemotherapy followed by mastectomy for locally advanced breast cancer. J Surg Oncol 22(4):278–282

    Article  CAS  PubMed  Google Scholar 

  3. Perloff M, Lesnick GJ (1982) Chemotherapy before and after mastectomy in stage III breast cancer. Arch Surg 117(7):879–881

    Article  CAS  PubMed  Google Scholar 

  4. Swain SM, Sorace RA, Bagley CS, Danforth DN Jr, Bader J, Wesley MN, Steinberg SM, Lippman ME (1987) Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res 47(14):3889–3894

    CAS  PubMed  Google Scholar 

  5. Fisher BBA, Mamounas E, Wieand S, Robidoux A, Margolese RG, Cruz AB Jr, Fisher ER WD, Wolmark N et al (1997) Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15(7):2483–2493

    CAS  PubMed  Google Scholar 

  6. Mamounas EP (1997) NSABP Protocol B-27. Preoperative doxorubicin plus cyclophosphamide followed by preoperative or postoperative docetaxel. Oncology (Williston Park) 11(6 Suppl 6):37–40

    CAS  Google Scholar 

  7. Mieog JS, van der Hage JH, van de Velde CJ (2007) Preoperative chemotherapy for women with operable breast cancer. Cochrane Database Syst Rev 2(18):CD005002

    PubMed  Google Scholar 

  8. Cortazar PZL, Untch M et al (2014) Pathological complete response and long-term benefit in breast cancer: the CT NeoBC pooled analysis. Lancet 384:164–172

    Article  PubMed  Google Scholar 

  9. Mathew J, Asgeirsson KS, Cheung KL, Chan S, Dahda A, Robertson JF (2009) Neoadjuvant chemotherapy for locally advanced breast cancer: a review of the literature and future directions. Eur J Surg Oncol 35(2):113–122

    Article  CAS  PubMed  Google Scholar 

  10. Kaufmann M, von Minchkwitz G, Bear HD et al (2007) Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. Ann Oncol 18:1927–1934

    Article  CAS  PubMed  Google Scholar 

  11. Christy CJ, Thorsteinsson D, Grube BJ, Black D, Abu-Khalaf M, Chung GG, DiGiovanna MP, Miller K, Higgins SA, Weidhaas J et al (2009) Preoperative chemotherapy decreases the need for re-excision of breast cancers between 2 and 4 cm diameter. Ann Surg Oncol 16(3):697–702

    Article  PubMed  Google Scholar 

  12. Kümmel SHJ, Loibl S (2014) Surgical treatment of primary breast cancer in the neoadjuvant setting. Br J Surg 101(8):912–924

    Article  PubMed  Google Scholar 

  13. Freedman RA, Partridge A (2013) Management of breast cancer in very young women. Breast 22(Suppl 2):S:176–S:179

    Article  Google Scholar 

  14. Guarneri VBK, Kau SW et al (2006) Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone status and other factors. J Clin Oncol 24(7):1037–1044

    Article  PubMed  Google Scholar 

  15. Cristofanilli M, Cristofanilli M, Gonzalez-Angulo A, Sneige N et al (2005) Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol 23(1):41–48

    Article  PubMed  Google Scholar 

  16. Mathew JAK, Jackson LR, Cheung KL, Robertson JF (2009) Neoadjuvant endocrine treatment in primary breast cancer – review of literature. Breast 6(18):339–344

    Article  Google Scholar 

  17. Charehbili A, Fontein D, Kroep JR, Liefers GJ, Mieog JS, Nortier JW, van de Velde CJ (2014) Neoadjuvant hormonal therapy for endocrine sensitive breast cancer: a systematic review. Cancer Treat Rev 1(40):86–92

    Article  Google Scholar 

  18. Semiglazov VF, Semiglazov V, Dashyan GA et al (2007) Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer. Cancer 2(110):244–254

    Article  Google Scholar 

  19. Alba E, Calvo L, Albanell J, De la Haba JR, Arcusa Lanza A, Chacon JI, Sanchez-Rovira P, Plazaola A, Lopez Garcia-Asenjo JA, Bermejo B, Carrasco E, Lluch A, GEICAM (2012) Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study. Ann Oncol 12(23):3069–3074

    Article  Google Scholar 

  20. MCcCarty KS Jr, Silva J, Cox EB et al (1983) Relationship of age and menopausal status to estrogen receptor content in primary carcinoma of the breast. Ann Surg 197:123–127

    Article  Google Scholar 

  21. Early breast cancer trialists collaborative group. 2000 analysis overview results. Fifth meeting of early breast cancer trialists collaborative group. Oxford, September 2000, pp 21–23

    Google Scholar 

  22. Mieog JS, van der Hage J, van de Velde CJ (2007) Neoadjuvant chemotherapy for operable breast cancer. Br J Surg 10(94):1189–1200

    Article  Google Scholar 

  23. Milla-Santos A, Milla L, Calvo N, Portella J, Rallo L, Casanovas JM, Pons M, Rodes J (2004) Anastrozole as neoadjuvant therapy for patients with hormone-dependent, locally-advanced breast cancer. Anticancer Res 2C(24):1315–1318

    Google Scholar 

  24. Thomas JS, Julian H, Green RV, Cameron DA, Dixon MJ (2007) Histopathology of breast carcinoma following neoadjuvant systemic therapy: a common association between letrozole therapy and central scarring. Histopathology 2(51):219–226

    Article  Google Scholar 

  25. Ellis MJ, Suman VJ, Hoog J, Lin L, Snider J, Prat A, Parker S, Luo J, DeSchryver K, Allred DC, Esserman LJ, Unzeitig GW, Margenthaler J, Babiera GV, Marcom PK, Guenther JM, Watson MA, Leitch M, Hunt K, Olson JA (2011) Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype—ACOSOG Z1031. J Clin Oncol 29(17):2342–2349

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Segara DKI, Garber JE, Winer E, Harris L, Bellon JR, Birdwell R, Lester S, Lipsitz S, Iglehart J et al (2007) Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy? J Surg Oncol 96(6):474–480

    Article  PubMed  Google Scholar 

  27. Oh JL, Nguyen G, Whitman GJ, Hunt KK, Yu TK, Woodward WA, Tereffe W, Strom EA, Perkins GHBT (2007) Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy. Cancer 110(11):2420–2427

    Article  PubMed  PubMed Central  Google Scholar 

  28. Boughey JC, Florentia Peintinger M M.D., Meric-Bernstam F M.D., Perry AC P.A-.C., Hunt KK M.D., Babiera V M.D., Singletary SE M.D., Bedrosian I M.D., Lucci A M.D., Buzdar AU M.D., Pusztai L M.D., Ph.D., Kuerer HM M., Ph.D. (2006) Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer. Ann Surg 244:464–470

    PubMed  PubMed Central  Google Scholar 

  29. Damera A, Evans A, Cornford EJ et al (2003) Diagnosis if axillary nodal metastasis by ultrasound guided core biopsy in primary operable breast cancer. Br J Cancer 89:1310–1313

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Nason KS, Anderson B, Byrd DR, Dunnwald LK, Eary JF, Mankoff DA, Livingston R, Schmidt RA, Jewell K, Yeung RS et al (2000) Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer 89(11):2187–2194

    Article  CAS  PubMed  Google Scholar 

  31. Mamounas EP, Brown A, Anderson S, Smith R, Julian T, Miller B, Bear HD, Caldwell CB, Walker A, Mikkelson WM et al (2005) Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23(12):2694–2702

    Article  PubMed  Google Scholar 

  32. Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, Lebeau A, Liedtke C, von Minckwitz G, Nekljudova V, Schmatloch S, Schrenk P, Staebler A, Untch M (2013) Sentinel-lymph node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol 7:609–618

    Article  Google Scholar 

  33. Krag DN, Anderson S, Julian TB, Brown AM, Harlow SP, Ashikaga T, Weaver DL, Miller BJJL, Frazier TG et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8(10):881–888

    Article  CAS  PubMed  Google Scholar 

  34. Goyal A, Newcombe R, Chhabra A, Mansel RE, ALMANAC Trialists Group (2006) Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer – results of the ALMANAC validation phase. Breast Cancer Res Treat 99(2):203–208

    Article  PubMed  Google Scholar 

  35. Xing Y, Foy M, Cox DD, Kuerer HM, Hunt KK, Cormier JN (2006) Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 5:539–543

    Article  Google Scholar 

  36. van Deurzen CH, Vriens B, Tjan-Heijnen VC, van der Wall E, Albregts M, van Hilligersberg R, Monninkhof EM, van Diest PJ (2009) Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review. Eur J Cancer 18:3124–3130

    Article  Google Scholar 

  37. Kelly AM, Dwamena B, Cronin P, Carlos RC (2009) Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy-systematic review and meta-analysis. Acad Radiol 16:551–563

    Article  PubMed  Google Scholar 

  38. Tan VK, Goh B, Fook-Chong S, Khin LW, Wong WK, Yong WS (2011) The feasibility and accuracy of sentinel lymph node biopsy in clinically node-negative patients after neoadjuvant chemotherapy for breast cancer – a systematic review and meta-analysis. J Surg Oncol 1:97–103

    Article  Google Scholar 

  39. Fu J-F, Chen H-L, Yang J, Yi C-H, Zheng S (2014) Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: a meta-analysis. PLoS One 9:e105316

    Article  PubMed  PubMed Central  Google Scholar 

  40. Boughey JC M.D., Suman J Ph.D., Mittendorf EA M.D., Ph.D., Ahrendt GM M.D., Wilke LG M.D., Taback B M.D., Leitch AM M.D., Kuerer HM M.D., Ph.D., Bowling M M.D., Flippo-Morton TS M.D., Byrd R M.D., Ollila DW M.D., Julian TB M.D., McLaughlin SA M.D., McCall L M.S., Symmans WF M.D., Le-Petross HT M.D., Haffty BG M.D., Buchholz TA M.D., Nelson H Md., Hunt KK M.D., for the Alliance for Clinical, Oncology Ti (2013) Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer the ACOSOG Z1071 (alliance) clinical trial. JAMA 14:1455–1461

    Article  Google Scholar 

  41. Boileau JF, Poirier B, Basik M, Holloway CM, Gaboury L, Sideris L, Meterissian S, Arnaout A, Brackstone M, McCready DR, Karp SE, Trop I, Lisbona A, Wright FC, Younan RJ, Provencher L, Patocskai E, Omeroglu A, Robidoux A (2015) Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SNFNAC study. J Clin Oncol 3:258–264

    Article  Google Scholar 

  42. Kang SHKJ, Choi EA, Lee ES (2004) Sentinel lymph node biopsy after neoadjuvant chemotherapy. Breast Cancer 11(3):233–241

    Article  PubMed  Google Scholar 

  43. Veronesi PGO, Fernandez JR, Magnoni F (2009) Breast conservation and sentinel lymph node biopsy after neoadjuvant systemic therapy. Breast 18(3):S90–S92

    Article  PubMed  Google Scholar 

  44. Alvarado R et al (2012) The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer. Ann Surg Oncol 19:3177–3184

    Article  PubMed  Google Scholar 

  45. Dominici S et al (2010) Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer. Cancer 116:284–289

    Article  Google Scholar 

  46. van der Hage JA, van de Velde C, Julien JP, Tubiana-Hulin M, Vandervelden C, Duchateau L (2001) Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 22:4224–4237

    Google Scholar 

  47. Clough KB, Ihrai T, Oden S, Kaufman G, Massey E, Nos C (2012) Oncoplastic surgery for breast cancer based on tumour location and a quadrant-per-quadrant atlas. Br J Surg 99(10):1389–1395

    Article  CAS  PubMed  Google Scholar 

  48. Clough KB, Soussaline M, Campana F, Salmon RJ (1990) Mammoplasty combined with irradiation: conservative treatment of cancers located in the lower quadrants. Ann Chir Plast Esthet 35(2):117–122

    CAS  PubMed  Google Scholar 

  49. Spear SL, Pelletiere C, Wolfe AJ et al (2002) Experience with reduction mammoplasty combined with breast conservation therapy in the treatment of breast cancer. Plast Reconstr Surg 111(3):1102–1109

    Article  Google Scholar 

  50. Petit JY, Rietjens M, Garusi C et al (1998) Integration of plastic surgery in the course of breast-conserving surgery for cancer to improve results and radicality of tumor excision. Recent Results Cancer Res 152:202–211

    Article  CAS  PubMed  Google Scholar 

  51. Cothier-Savey I, Otmezguine Y, Calitchi E et al (1996) Value of reduction mammoplasty in the conservative treatment of breast neoplasm. A propos of 70 cases. Ann Chir Plast Esthet 41(4):346–353

    CAS  PubMed  Google Scholar 

  52. Mazouni C, Naveau A, Kane A, Dunant A, Garbay JR, Leymarie N, Sarfati B, Delaloge S, Rimareix F (2013) The role of oncoplastic breast surgery in the management of breast cancer treated with primary chemotherapy. Breast 22(6):1189–1193

    Article  PubMed  Google Scholar 

  53. Schaverien MV, Doughty J, Stallard S (2014) Quality of information reporting in studies of standard and oncoplastic breast conserving surgery. Breast 23(2):104–111

    Article  CAS  PubMed  Google Scholar 

  54. Yang JD, Lee JW, Cho YK, Kim WW, Hwang SO, Jung JH, Park HY (2012) Surgical techniques for personalized oncoplastic surgery in breast cancer patients with small- to moderate-sized breasts (part 1): volume displacement. J Breast Cancer 15(1):1–6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Bulstrode NW, Shrotria S (2001) Prediction of cosmetic outcome following breast conservation surgery using breast volume measurements. Breast 10:124–126

    Article  CAS  PubMed  Google Scholar 

  56. Kaur N, Petit J, Rietjens M et al (2005) Comparative study of surgical margins in oncoplastic surgery and quadrantectomy in breast cancer. Ann Surg Oncol 12(7):539–545

    Article  PubMed  Google Scholar 

  57. McCulley SJ, Macmillan R (2005) Therapeutic mammaplasty: analysis of 50 consecutive cases. Br J Plast Surg 58(7):902–907

    Article  CAS  PubMed  Google Scholar 

  58. McCulley SJ, Macmillan RD (2005) Planning and use of therapeutic mammoplasty – Nottingham approach. Br J Plast Surg 58:889–901

    Article  CAS  PubMed  Google Scholar 

  59. Benelli L (1990) A new periareolar mammaplasty: the “round block” technique. Aesthet Plast Surg 14(2):93–100

    Article  CAS  Google Scholar 

  60. Gasperoni C, Salgarello M, Gasperoni P (2002) A personal technique: mammaplasty with J scar. Ann Plast Surg 48(2):124–130

    Article  PubMed  Google Scholar 

  61. Anderson BO, Masetti R, Silverstein MJ (2005) Oncoplastic approaches to partial mastectomy: an overview of volume-displacement techniques. Lancet Oncol 6:145–157

    Article  PubMed  Google Scholar 

  62. McCulley SJ, Durani P, Macmillan RD (2006) Therapeutic mammoplasty for centrally located breast tumours. Plast Reconstr Surg 117(2):366–373

    Article  CAS  PubMed  Google Scholar 

  63. Hamdi M, Van Landuyt K, Monstrey S et al (2004) Pedicled perforator flaps in breast reconstruction: a new concept. Br J Plast Surg 57:531–539

    Article  PubMed  Google Scholar 

  64. Hamdi M, Van Landuyt K, Blondeel P, Hijjawi B, Roche N, Monstrey S (2009) Autologous breast augmentation with the lateral intercostal artery perforator flap in massive weight loss patients. J Plast Reconstr Aesthet Surg 62:65–70

    Article  PubMed  Google Scholar 

  65. Bank J, Ledbetter K, Song DH (2014) Use of thoracodorsal artery perforator flaps to enhance outcomes in alloplastic breast reconstruction. Plast Reconstr Surg Glob Open 2(5):e140

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Royal Derby Hospital Centre, University of Nottingham, Uttoxeter Road, Derby, DE22 3DT, UK

    John Mathew, Carol-Ann Courtney & John F. Robertson

  2. The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Kelly K. Hunt

Authors
  1. John Mathew
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carol-Ann Courtney
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kelly K. Hunt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John F. Robertson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John F. Robertson .

Editor information

Editors and Affiliations

  1. Department of Breast Surgery Graduate Sc, Kyoto University, Kyoto, Kyoto, Japan

    Masakazu Toi

  2. Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA

    Eric Winer

  3. Addenbrooke’s Hospital, Cambridge University Hospitals, Cambridge, Cambridgeshire, United Kingdom

    John Benson

  4. University of Arkansas for Medical Scien, Little Rock, Arkansas, USA

    Suzanne Klimberg

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Japan

About this chapter

Cite this chapter

Mathew, J., Courtney, CA., Hunt, K.K., Robertson, J.F. (2016). Surgical Management of Breast Cancer After Preoperative Systemic Treatment. In: Toi, M., Winer, E., Benson, J., Klimberg, S. (eds) Personalized Treatment of Breast Cancer. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55552-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-55552-0_17

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-55551-3

  • Online ISBN: 978-4-431-55552-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation